Our Founders
ThinkSono was founded in 2016 by Fouad Al Noor and Sven Mischkewitz. The two met at the prestigious Entrepreneur First (EF) program in London where they found a common interest in improving access to medical diagnostics worldwide.
Fouad Al Noor
Chief Executive Officer
Co-Founder
Fouad has a masters in Electronic Engineering with Nanotechnology from the University of Southampton, where he wrote his thesis on paper-based medical diagnostics using image processing. He worked as a medical software engineer at SAP in California, and as a research assistant at Imperial College London before joining Entrepreneur First.
Sven Mischkewitz
Chief Technology Officer
Co-Founder
Team
We are working towards a world where ultrasound diagnosis can be provided safely at the point of care by any healthcare professional leading to lower diagnostic cost, reduced wait times and better patient care.
Michael Blaivas, MD, MBA, FACEP, FAIUM
Chief Medical Officer
Prof.Blaivas has more than 22 years of experience in combining innovation, technology, medical research and clinical fundamentals to create new products, improve existing processes and generate growth. An engineering and computer science background, out-of-the-box thinking, as well as broad and deep experience in medical device and software development have allowed him to successfully partner with companies from 2 person startups to multi-billion dollar conglomerates.
Dr. Bernhard Kainz
Scientific Lead & Machine Learning Consultant
Dr. Mattias Heinrich
Scientific Lead & Machine Learning Consultant
Soren Tietböhl
Software Engineer
Beverley Scott
Chief Safety Officer
Beverley Scott supports ThinkSono with regulatory compliance and safety. She has broad and expert knowledge of the regulatory and standards landscape for medical devices, software as a medical device, health technology and medical apps. Beverly is a a Registered, practising nurse with 23 years’ clinical experience in working with people with eating disorders, 18 years working in patient safety and information governance and 5 years in dermatology, skincare and aesthetics.
Jonas Oppenheimer, MD
Lead Medical Analyst
Giancarlo Speranza, MBA, MD
Clinical Consultant, Vascular Surgery
Dr Speranza has completed a five-year MD/MBA program at the NYU Grossman School of Medicine, applying into vascular surgery during the 2023-2024 cycle. He is supporting the company in setting up and running multi-centred clinical trials in the U.S in at NYU Langone Health, Temple Health and other sites. He is also supporting the company in writing research papers and in connecting with key opinion leaders.
Advisors
Our advisors have decades of experience in radiology, vascular surgery and haematology as well as commercialisation of medical technologies.
Dr. Ramin Mandegaran, MBBS BSc FRCR FRCPC
Radiologist & Clinical Advisor
Dr. Mandegaran is a Consultant Musculoskeletal Radiologist in Alberta, Canada, previously of Guy’s & St. Thomas’ Hospital in central London. He has presented at numerous international conferences, published multiple papers and has a particular interest in ultrasound, with many years’ practical experience with DVT diagnosis.
Dr. Efthymios Avgerinos
Professor of Surgery University of Pittsburgh
Dr. Avgerinos is Professor of Surgery and has been a faculty of the University of Pittsburgh since 2011. He has authored or co-authored more than 200 peer reviewed publications and chapters on vascular surgery and his work has been widely cited and recognized with international awards. Particularly for venous disease he has been focusing on acute DVT interventions.
Dr. Nicola Curry
Consultant Haematologist – Oxford University Hospital
Dr. Curry is the Head of Department for the Oxford Haemophilia and Thrombosis Centre, which specialises in the care of inherited and acquired bleeding and thrombotic disorders. Her research focuses on the better understanding of the pathophysiology of trauma coagulopathy and in particular the influence of the endothelium on the evolution of the coagulopathy and the associated bleeding.
Dr. Raham Karimaghaei, MBBS BSc FRCR
Diagnostic & Interventional Radiologist, Clinical Advisor
Dr Karimaghaei trained in Medicine at St George’s Hospital in London, and then gained extensive experience in Emergency Medicine before undertaking specialist Radiological and Interventional training in leading London Hospitals including St George’s, Great Ormond street, and the Royal Marsden.
Gregg Sando, MBA, MSc
Board Member
Gregg has a B.A. Biochemistry from Harvard University, an M.B.A. University of Chicago and an MSc Immunology, Imperial College London. After a career in investment banking based both in London and New York, he completed his Immunology MSc degree at the medical school of Imperial College. Recognising the significant progress taking place in the field of cellular immunotherapy, Gregg formed Cell Medica in cooperation with a small group of the leading clinicians and immunologists who were pioneering this new mode of medical treatment.
R&D
PARTNERS
RESEARCH FUNDING
SUPPORTED BY TOP TIER INVESTORS
